Metabolic resilience—the body's capacity to adapt to nutritional and inflammatory stressors while maintaining functional stability—emerges as the key factor explaining why dietary interventions show such inconsistent results in aging populations. The framework centers on the AMPK-mTOR-SIRT1 axis, where declining energy-sensing pathways and chronic inflammation progressively impair adaptive capacity with age. This represents a paradigm shift from viewing inconsistent dietary trial results as methodological failures to recognizing them as reflections of underlying biological heterogeneity. The implications are profound for nutrition research design and clinical practice. Rather than pursuing one-size-fits-all dietary recommendations, this framework suggests stratifying interventions based on individual metabolic resilience profiles. It explains why caloric restriction works for some but not others, why anti-inflammatory diets show variable effects, and why short-term biomarkers often fail to predict long-term outcomes. For practitioners, this means assessing functional reserve and inflammatory burden before prescribing dietary changes. The approach could revolutionize personalized nutrition by moving beyond simple nutrient targeting toward comprehensive metabolic phenotyping, potentially unlocking more consistent and clinically meaningful results in aging populations.